Scar Prevention Overview

Principles

Definition

Scar prevention is a specialized area of biomedical research and clinical intervention dedicated to identifying and modulating the biological pathways involved in wound healing to minimize the development of undesirable scar tissue. It encompasses the study of cellular, molecular, and genetic factors influencing extracellular matrix deposition and tissue remodeling, the evaluation of therapeutic modalities, and the implementation of strategies aimed at achieving optimal cosmetic and functional post-injury outcomes.

Ontological type

Clinical Techniques

Biological Mechanisms

Pharmacologic Therapies

Key developments

Key Figures

Collagen–Mechanics Paradigm era

Duane L. Larson [1] was associated with The University of Texas Medical Branch at Galveston [3] and Galveston College [4] during this era. His key contributions included techniques for decreasing scar formation and contractures in the burned patient [6], and investigations into hypertrophic scar hexosamine-containing components [7], which helped connect mechanical insults and scar biochemistry to practical prevention strategies. William H. Eaglstein [2] was affiliated with the University of Miami [5] during this era. His sole paper, New Method for Assessing Epidermal Wound Healing: The Effects of Triamcinolone Acetonide and Polyethelene Film Occlusion [8], introduced assessment methods and showed how topical steroids and occlusion modulate epidermal healing, contributing to scar prevention strategies by shaping how the wound mechanical milieu is optimized.

Molecular Growth‑Factor Era era

Louis C. Argenta [1] worked across Washington University in St. Louis [3] and Wake Forest University [4] during the Molecular Growth‑Factor Era (1982–1998). His key contribution was the Vacuum-Assisted Closure method, as described in Vacuum-Assisted Closure: A New Method for Wound Control and Treatment [6], representing a major advance in wound management aligned with this era's emphasis on enhanced dressings and delivery systems. Thomas A. Mustoe [2] was associated with Harvard University [5] and Washington University in St. Louis [3] during the Molecular Growth‑Factor Era (1982–1998). His contributions are reflected in three papers: Accelerated Healing of Incisional Wounds in Rats Induced by Transforming Growth Factor-β [7], Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor [8], and In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins [9], which collectively illustrate how TGF-β and PDGF signaling can enhance healing and potentially reduce scarring in this era.

Biomaterial‑Regenerative Era era

Baolin Guo [1], affiliated with China Agricultural University [3] and Air Force Medical University [4], emerged as a key figure in the Biomaterial-Regenerative Era of scar prevention. His work on Physical Double‐Network Hydrogel Adhesives with Rapid Shape Adaptability, Fast Self‑Healing, Antioxidant and NIR/pH Stimulus‑Responsiveness for Multidrug‑Resistant Bacterial Infection and Removable Wound Dressing [7] and Conductive adhesive self-healing nanocomposite hydrogel wound dressing for photothermal therapy of infected full‑thickness skin wounds [8] delivered rapid, programmable, stimulus‑responsive properties that enable spatiotemporal control of the wound milieu, advancing anti‑scar strategies in this era. Mark W. J. Ferguson [2], associated with Utrecht University [5] and the University of Manchester [6], contributed to early translational approaches in scar prevention. His prophylactic administration of avotermin studies [9] and the expression of TGF-beta and its receptors in murine fetal and adult dermal wounds [10] helped define therapeutic timing and molecular pathways to steer healing away from fibrosis in this era.